European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...

European Union approves GSK’s Blenrep combinations to treat relapsed/refractory multiple myeloma: London, UK Saturday, July 26, 2025, 11:00 Hrs [IST] GSK plc announced the appro ...

Shares of health coverage company Centene (NYSE:CNC) jumped 5.9% in the afternoon session after the company reported ...

London's main stock indexes rose on Thursday, with the blue-chip index hitting an all-time intraday peak, boosted by upbeat ...

KRd as a potential standard-of-care regimen in this hard-to-treat population of high-risk, newly diagnosed multiple myeloma,” said Lisa B. Leypoldt, MD.